Lv4
481 积分 2021-03-16 加入
Epidermal growth factor receptor (EGFR) atypical mutations in non-small-cell lung cancer (NSCLC): ‘Where the streets have no name’
4天前
已完结
基于NGS的肿瘤全景变异检测探针设计专家共识（2026版）
12天前
已完结
基于NGS的肿瘤全景变异检测探针设计专家共识（2026版）
12天前
已完结
Clinical Implementation of Expanded Solid Tumor Fusion Detection With Whole-Transcriptome Sequencing at an Academic Cancer Center
1个月前
已完结
Trends in target novelty in oncology R&D
3个月前
已完结
Recent update on the development of EZH2 inhibitors and degraders for cancer therapy
3个月前
已完结
Minimal residual disease as a target for liquid biopsy in patients with solid tumours
4个月前
已完结
Evolving roles of MET as a therapeutic target in NSCLC and beyond
4个月前
已完结
Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches
4个月前
已完结
Vebreltinib effective in MET-amplified NSCLC
4个月前
已完结
皖公网安备34019202002308
